21st Apr 2005 12:12
Allergy Therapeutics PLC21 April 2005 Schedule 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Allergy Therapeutics plc 2. Name of shareholder having a major interest Fidelity International Limited 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 Non-beneficial interest 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them Nominee/registered name Share held Management Company JP Morgan, Bournemouth 849,300 Fidelity Inv Services LtdBank of New York, Brussels 441,562 Fidelity Pension Mgmnt (FPM)Bankers Trust London 135,700 FPMCITIBANK London 128,400 FPMClydesdale Bank plc 58,300 FPMJP Morgan, Bournemouth 288,500 FPMMcllon Bank 307,900 FPMMidland Securities Services 74,300 FPMNorthern Trust London 609,300 FPMState STR BK and TR Co London 214,598 FPMBrown Bros Harrimn Ltd LUX 350,000 FPM 5. Number of shares / amount of stock acquired 910,860 6. Percentage of issued class 1.447% 7. Number of shares / amount of stock disposed - 8. Percentage of issued class - 9. Class of security Ordinary shares 10. Date of transaction Not notified 11. Date company informed 20th April 2005 12. Total holding following this notification 3,457,860 13. Total percentage holding of issued class following this notification 5.49% 14. Any additional information Notifiable interest also comprises of Mr. Edward C. Johnson 3d A principleShareholder of Fidelity International Limited 15. Name of contact and telephone number for queries Ian Postlethwaite - 01903 844 721 16. Name and signature of authorised company official responsible for makingthis notification Ian Potlethwaite Date of notification 20 April 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.